Skip to content

Assessment of Accelerometric Measurement Devices for Gait Analysis

Assessment of Accelerometric Measurement Devices for Gait Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01522690
Acronym
ACCELERIX
Enrollment
300
Registered
2012-02-01
Start date
2011-12-31
Completion date
2015-12-31
Last updated
2016-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Accelerometer, gait analysis, Healthy subjects

Brief summary

The objective of this study is to obtain normative accelerometry data during the six minute walk test and a 30 second walk test on healthy subjects in order to determine the accelerometric variables that are the most relevant to describe gait disorders in patient populations. Secondary objectives of this study are to investigate the impact of walking speed and muscle strength on the accelerometric parameters, to assess the reproducibility of the method and to compare accelerometric data obtained with two different devices.

Interventions

OTHERDifferent walk tests with an accelerometer device

Subjects will performed three walk tests of 50 meter at different speeds, a six minute walk test, a walking test of 30 seconds then a test to measure the maximum force of extension and knee flexion on each leg. The walk tests will be performed with the accelerometer device (Locometrix) worn in a belt

Sponsors

Institut de Myologie, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy ambulant subject * subject affiliated to a social security system * subject who signed an informed consent

Exclusion criteria

* surgery or recent trauma to the lower limbs (under 6 months) * high performance sport * chronic treatment alters the strength in the month before inclusion * pregnant or nursing woman * person under guardianship or curatorship * orthopedic, neuromuscular or neurological disease having an impact on the quality of walking

Design outcomes

Primary

MeasureTime frame
Accelerometric variables measured for each walk testAt baseline

Secondary

MeasureTime frame
Gait speed measured for each walk testAt baseline
Knee flexion and extension strengthAt baseline

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026